top of page

BackTable / Urology / Podcast / Episode #280

Genomic Classifiers in Bladder Cancer Management

with Dr. Carissa Chu

Can genomic classifiers close the gap between what we see and what a tumor will do? In this episode of BackTable Urology, Dr. Carissa Chu (UCSF) joins Dr. Ruchika Talwar (Vanderbilt) to explore how genomic classifiers are reshaping the way clinicians diagnose and manage bladder cancer.

This podcast is supported by:

Be part of the conversation. Put your sponsored messaging on this episode. Learn how.

Genomic Classifiers in Bladder Cancer Management with Dr. Carissa Chu on the BackTable Urology Podcast
Ep 280 Genomic Classifiers in Bladder Cancer Management with Dr. Carissa Chu
00:00 / 01:04

BackTable, LLC (Producer). (2025, December 16). Ep. 280 – Genomic Classifiers in Bladder Cancer Management [Audio podcast]. Retrieved from https://www.backtable.com

Stay Up To Date

Follow:

Subscribe:

Sign Up:

Podcast Contributors

Dr. Carissa Chu on the BackTable Urology Podcast

Dr. Carissa Chu is a urologist and Assistant Professor of Urology at UCSF in San Francisco, California.

Dr. Ruchika Talwar on the BackTable Urology Podcast

Dr. Ruchika Talwar is a urologic oncologist at Vanderbilt University Medical Center in Nashville, Tennessee.

Synopsis

They discuss the limitations of traditional staging systems and how molecular subtyping is providing deeper insight into tumor biology, treatment response, and prognosis. Dr. Chu highlights where these classifiers can be integrated into real-world clinical decision-making today, where the evidence is still emerging, and which ongoing trials may define the next era of precision medicine in urologic oncology.

Timestamps

0:00 - Introduction
3:01 - Overview of Genomic Classifiers
9:34 - Risk Stratification
15:22 - Current Evidence for Genomic Classifiers
22:07 - Clinical Implications of Biomarkers
27:23 - Ordering Genomic Classifiers
33:46 - Future Directions
37:57 - Final Takeaways

Resources

Alignment of molecular subtypes across multiple bladder cancer subtyping classifiers
https://pubmed.ncbi.nlm.nih.gov/38480079/

GUSTO Trial
https://fundingawards.nihr.ac.uk/award/NIHR128103

The Materials available on BackTable are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

backtable-plus-vi-cta.jpg
Become a BackTable Sponsor

Up Next

NMIBC Tumor Board: Upper Tract Challenges with Dr. Mark Tyson and Dr. Sarah Psutka on the BackTable Urology Podcast
NMIBC Tumor Board: Nuances in Management with Dr. Mark Tyson and Dr. Sarah Psutka on the BackTable Urology Podcast
Techniques & Challenges in Bladder Transplant Surgery with Dr. Nima Nassiri on the BackTable Urology Podcast
Enhancing Care Coordination in Bladder Cancer Treatments with Brynn Moore and Meredith Donahue on the BackTable Urology Podcast
How Biomarkers Enhance Precision Medicine in Non-Muscle Invasive Bladder Cancer with Dr. Katie Murray and Dr. Sarah Psutka on the BackTable Urology Podcast
Optimizing Bladder Health in BPH Treatment Strategies with Dr. Shawn West on the BackTable Urology Podcast

Articles

Topics

Get in touch!

We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.

bottom of page